The mechanisms by which TZDs exert their insulin sensitizing action in skeletal muscle of type 2 diabetic patients are not yet fully understood, but may include increased downstream insulin receptor signaling [10], [11] and enhanced fatty acid uptake and oxidation [12], [13]. This evidence concerns the gene INS and type 2 diabetes mellitus.